What is Jasper Therapeutics, Inc. Common Stock's Market Cap?

Jasper Therapeutics, Inc. Common Stock's Market Cap is $23.6M, based on as-reported figures from SEC (XBRL) filings.

What is Jasper Therapeutics, Inc. Common Stock's Enterprise Value?

Jasper Therapeutics, Inc. Common Stock's Enterprise Value is -$5.1M, based on as-reported figures from SEC (XBRL) filings.

What is Jasper Therapeutics, Inc. Common Stock's EV / EBITDA?

Jasper Therapeutics, Inc. Common Stock's EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.

What is Jasper Therapeutics, Inc. Common Stock's Net Income (TTM)?

Jasper Therapeutics, Inc. Common Stock's Net Income (TTM) is -$75.8M, based on as-reported figures from SEC (XBRL) filings.

What is Jasper Therapeutics, Inc. Common Stock's EBITDA?

Jasper Therapeutics, Inc. Common Stock's EBITDA is -$82.8M, based on as-reported figures from SEC (XBRL) filings.

What is Jasper Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Jasper Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.28, based on as-reported figures from SEC (XBRL) filings.

What is Jasper Therapeutics, Inc. Common Stock's Net Debt?

Jasper Therapeutics, Inc. Common Stock's Net Debt is -$28.7M, based on as-reported figures from SEC (XBRL) filings.

Jasper Therapeutics, Inc. Common Stock (JSPR) Financial Statements

Jasper Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00QPZNPB4

XNAS · usd

0.71▲ 0.00 (0.11%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.71

Day's Range0.70 – 0.74

52-Week Range0.32 – 2.78

Volume189.8K

Avg Volume631.0K

Share Statistics

Shares Outstanding

Employees22

ExchangeXNAS

Listed2021-09-27

Share count as of August 10, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Jasper Therapeutics, Inc. Common Stock (JSPR)

What is Jasper Therapeutics, Inc. Common Stock's Market Cap?: Jasper Therapeutics, Inc. Common Stock's Market Cap is $23.6M, based on as-reported figures from SEC (XBRL) filings.
What is Jasper Therapeutics, Inc. Common Stock's Enterprise Value?: Jasper Therapeutics, Inc. Common Stock's Enterprise Value is -$5.1M, based on as-reported figures from SEC (XBRL) filings.
What is Jasper Therapeutics, Inc. Common Stock's EV / EBITDA?: Jasper Therapeutics, Inc. Common Stock's EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is Jasper Therapeutics, Inc. Common Stock's Net Income (TTM)?: Jasper Therapeutics, Inc. Common Stock's Net Income (TTM) is -$75.8M, based on as-reported figures from SEC (XBRL) filings.
What is Jasper Therapeutics, Inc. Common Stock's EBITDA?: Jasper Therapeutics, Inc. Common Stock's EBITDA is -$82.8M, based on as-reported figures from SEC (XBRL) filings.
What is Jasper Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Jasper Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -2.28, based on as-reported figures from SEC (XBRL) filings.
What is Jasper Therapeutics, Inc. Common Stock's Net Debt?: Jasper Therapeutics, Inc. Common Stock's Net Debt is -$28.7M, based on as-reported figures from SEC (XBRL) filings.